This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martins-Filho, O. A. Articles by Brener, Z. Search for Related Content PubMed PubMed Citation Articles by Martins-Filho, O. A. Articles by Brener, Z.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 09 1995, 569-573, Vol 2, No. 5
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease

OA Martins-Filho, ME Pereira, JF Carvalho, JR Cancado and Z Brener
Centro de Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, MG, Brazil.

Sera from patients chronically infected with Trypanosoma cruzi display antibodies that bind to epitopes of living trypomastigotes, known as lytic antibodies (LA), and are detected by a complement-mediated lysis test. Conventional serology antibodies (CSA) are also present in sera from patients with chronic infections but, in contrast to LA, are unable to recognize viable trypomastigotes. The presence of LA has been used as an important element in the criterion of cure in human Chagas' disease. Using flow cytometry technology, we introduced a new and sensitive immunomethod for the detection of anti-live trypomastigote membrane-bound antibodies. On the basis of serological tests (LA and CSA detection) and parasitological assays such as hemoculture (HE), patients were classified into the following groups: chronically infected untreated patients (NT) and treated not-cured patients (TNC), with positive HE and both LA and CSA in their sera; "dissociated" HE- negative patients (DIS), in whom LA was not detected whereas CSA were present; a group of cured HE-negative patients (CUR), who were both LA and CSA negative; and, as control, a group of non-chagasic individuals (NC). Sera from these patients were assayed by incubation with live bloodstream trypomastigotes, which were subsequently exposed to fluorescein isothiocyanate-conjugated anti-human immunoglobulin G. The parasites were then fixed, run in the cytometer, and identified on basis of their size and granularity gain adjustments. On the basis of experience with the complement-mediated lysis test, a level of 20% of parasites being fluorescein isothiocyanate fluorescence positive was used as a cutoff between effective and ineffective treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

• Lemos, E. M., Gomes, I. T., Carvalho, S. F. G., Rocha, R. D. R., Pissinate, J. F., Martins-Filho, O. A., Dietze, R. (2007). Detection of Anti-Leishmania (Leishmania) chagasi Immunoglobulin G by Flow Cytometry for Cure Assessment following Chemotherapeutic Treatment of American Visceral Leishmaniasis. CVI 14: 569-576 [Abstract] [Full Text]  
• Shadomy, S. V., Waring, S. C., Chappell, C. L. (2004). Combined Use of Enzyme-Linked Immunosorbent Assay and Flow Cytometry To Detect Antibodies to Trypanosoma cruzi in Domestic Canines in Texas. CVI 11: 313-319 [Abstract] [Full Text]  
• Pereira-Chioccola, V. L., Fragata-Filho, A. A., Levy, A. M. d. A., Rodrigues, M. M., Schenkman, S. (2003). Enzyme-Linked Immunoassay Using Recombinant trans-Sialidase of Trypanosoma cruzi Can Be Employed for Monitoring of Patients with Chagas' Disease after Drug Treatment. CVI 10: 826-830 [Abstract] [Full Text]  
• Toledo, M. J. d. O., Bahia, M. T., Carneiro, C. M., Martins-Filho, O. A., Tibayrenc, M., Barnabe, C., Tafuri, W. L., de Lana, M. (2003). Chemotherapy with Benznidazole and Itraconazole for Mice Infected with Different Trypanosoma cruzi Clonal Genotypes. Antimicrob. Agents Chemother. 47: 223-230 [Abstract] [Full Text]  
• Martins-Filho, O. A., Eloi-Santos, S. M., Carvalho, A. T., Oliveira, R. C., Rassi, A., Luquetti, A. O., Rassi, G. G., Brener, Z. (2002). Double-Blind Study To Evaluate Flow Cytometry Analysis of Anti-Live Trypomastigote Antibodies for Monitoring Treatment Efficacy in Cases of Human Chagas' Disease. CVI 9: 1107-1113 [Abstract] [Full Text]  
• Cordeiro, F. D., Martins-Filho, O. A., Da Costa Rocha, M. O., Adad, S. J., Correa-Oliveira, R., Romanha, A. J. (2001). Anti-Trypanosoma cruzi Immunoglobulin G1 Can Be a Useful Tool for Diagnosis and Prognosis of Human Chagas' Disease. CVI 8: 112-118 [Abstract] [Full Text]  
• Molina, J., Urbina, J., Gref, R., Brener, Z., Rodrigues Junior, J. M. (2001). Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres. J Antimicrob Chemother 47: 101-104 [Abstract] [Full Text]  
• Molina, J., Brener, Z., Romanha, A. J., Urbina, J. A. (2000). In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J Antimicrob Chemother 46: 137-140 [Abstract] [Full Text]  
• Araujo, M. S. S., Martins-Filho, O. A., Pereira, M. E. S., Brener, Z. (2000). A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. J Antimicrob Chemother 45: 819-824 [Abstract] [Full Text]  
• Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
• Molina, J., Martins-Filho, O., Brener, Z., Romanha, A. J., Loebenberg, D., Urbina, J. A. (2000). Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan Parasite Trypanosoma (Schizotrypanum) cruzi in Immunocompetent and Immunosuppressed Murine Hosts. Antimicrob. Agents Chemother. 44: 150-155 [Abstract] [Full Text]